CBER is unanimously against Elevdiys’ return to the market without additional evidence, according to media reports citing an ...

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts ...

In after-hours trading, shares of Sarepta (SRPT) are down 9% to $10.90. Published first on TheFly – the ultimate source for real-time, ...

The European Union’s health regulatory agency did not endorse approving Elevidys for ambulatory patients with Duchenne ...

Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular ...

J.P. Morgan analyst Anupam Rama maintained a Buy rating on AnaptysBio today and set a price target of $80.00. The company’s shares opened today at $28.15. Take advantage of TipRanks Premium at 50% off ...

Second-quarter earnings for European companies have come in ahead of expectations, with financials and U.S.-exposed sectors leading the surprise, Bank of America (NYSE:BAC) (BofA) analysts said.

Detailed price information for General Dynamics Corp (GD-N) from The Globe and Mail including charting and trades.

Wall Street is ending the week on a quiet note, with stocks hovering near their all-time highs as traders digest the latest ...